In spinal fluid from mild cognitive impairment (MCI) AD patients, NRG1 levels are increased and associated with cognitive loss (Pankonin et al., 2009; Mouton-Liger et al., 2020; Vrillon et al., 2022). Here, NRG1 is linked to Alzheimer disease.